Liver cancer is the cancer type beginning in form of a tumor within the liver. The cells of a normal and healthy liver multiply at a definite, controlled rate without interrupting any of the organ’s surrounding cells. Abnormal growth of any of the liver cells or hepatocytes, blood vessels or bile duct cells leads to tumor formation. However, having tumors in the liver does not mean that one has become the victim of liver cancer. Liver tumors are either benign (noncancerous) or malignant (cancerous). Both men and woman can develop malignant tumors in their liver; these tumors have the potential of damaging other tissues of the patient’s body and spreading to other parts of his or her body. Individuals above the age of 40 years are at highest risk of suffering from this cancer type. The two primary liver cancer types are:

Primary liver cancer:

This liver cancer type starts from benign tumors. Growth in liver like focal nodular hyperplasias, hepatic adenomas and hemangiomas are generally benign, but can eventually develop into liver cancer. Primary liver cancers can also be caused by hepatitis B, hepatitis C, some kidney disorders, certain toxins, viral infections affecting the liver etc. There can be 3 subtypes of primary liver cancer; they are:

1. Hepatoma or Hepatocellular Carcinoma.
2. Bile duct cancers or Cholangiocarcinomas.
3. Hemangiosarcoma and Angiosarcomas.

Secondary liver cancer:

Liver cancers resulting from spreading of cancer cells from a body part located outside the liver are referred to as secondary liver cancers. The cancer might invade the liver from the gastrointestinal organs like colon, pancreas and stomach.

Race, gender and age:

Statistics suggest that liver cancer is 3 times more common in men compared to the women. This cancer type is more common in individuals above the age of 60 years; but the highest incidence of liver cancer is recorded in people aged between 70 years and 79 years. The races that are more at risk of developing liver cancer include: Pacific Islanders, African Americans, American Indians, Hispanics and Asians.

Hepatitis viral infections:

People suffering from chronic hepatitis B or hepatitis C viral infections are susceptible towards developing hepatocellular carcinoma. 78% of the patients having either of these infections suffer from hepatocellular carcinoma. Hepatitis C infections is the more common variety of hepatitis infections among people of USA and one of the leading causes of hepatocellular carcinoma among the residents of the country.

Liver diseases:

liver cirrhosis, autoimmune hepatitis, hemochromatosis, Wilson’s disease and nonalcoholic steatohepatitis are diseases that leave an individual at higher risk of having liver cancer. Out of these conditions, liver cirrhosis is known to be the most dangerous risk factor for liver cancer. Statistics suggest that 70% to 90% patients suffering from hepatocellular carcinoma has liver cirrhosis.

Alcohol:

People with alcohol addiction might develop a condition called fatty liver, which ultimately takes the shape of liver cirrhosis. A recent survey has revealed that a large share of patients with liver cirrhosis induced by alcohol intake suffer from hepatocellular carcinoma.

Obesity and diabetes:

People with type-2 diabetes are two times more at risk of suffering from hepatocellular carcinoma compared to individuals who do not have diabetes. On the other hand, a study conducted on over 900,000 people of USA have revealed that obese men are 5 times more likely to die from liver cancer than men with normal BMI. The chances of occurrence of liver cancer are even more in obese individuals with diabetes.

Jaundice:
Jaundice is a medical condition marked by yellowing of mucous membranes, which includes the skin, mouth’s lining and whites of eyes. Majority of the liver cancer patients in the final stage of the disease develop jaundice. Jaundice indicates presence of blockages in the liver and in case of final stage liver cancer it signifies shutdown of the liver. The gallbladder and liver of a healthy individual produce bile salts; the primary function of bile salts is aiding the process of digestion and breaking down the nutrients present in foods. Patients in the final stage of liver cancer develops blockage in their bile ducts due to growth of cancer cells; as a result of this bile salts leak and enters the patients’ bloodstream. The blood with bile chemicals then starts circulating into different tissues of the patient’s body causing discoloration or yellowing.

Decrease in lung capacity:
A patient in the final stage of liver cancer is also likely to experience decrease in lung capacity. During the end stage of liver cancer, the cancer cells develop the ability of metastasizing i.e. these cells can invade the patient’s lymph and blood vessels and reach other tissues and organs of his body. In majority of the cases, in this stage of liver cancer, the cancer cells start colonizing in the lung tissues forming secondary tumors. This spreading of the cancer changes the normal lung structure, which results in decrease in the air capacity of the patient’s lungs. In such situation, the liver cancer patients might experience symptoms like breathing difficulties, light headedness etc.

Bone pain:
In the final stage of liver cancer, the cancer often tends to metastasize into the bone tissues of different body parts of the patient. This makes bone related signs common among patients in the final stage of liver cancer. Cancer metastasis commonly cause bone pain in these patients. The bone pain might be sharp and stabbing in nature occurring as a response to particular movements or can be present in form of a radiating pain in certain joints.

Prognosis provides an estimate of the possible course & consequence of the condition – i.e. the likelihood of recovery or relapse of the disease. Factors affecting prognosis include, most importantly – the form, site of cancer, staging (level of metastasis), grading of cancer among others.

According to the ACS estimate, 18510 people from both genders would be identified with liver cancer & 16200 deaths from it occurred during 2006.

Liver cancer prognosis is dependent upon:

• Cancer staging (tumor size, if it has affected some section or the entire liver, or having metastasized to other body areas).
• The extent of liver functioning.
• Overall health of the patient inclusive of factor like presence/absence of liver cirrhosis.
• Levels of AFP or alpha fetoprotein.

Effect of Disease Staging on Liver Cancer Prognosis

Historically, here are the stark figures.

• Diagnosis of thirty-one percent liver cancer cases are yet restricted to the original location (localized staging).
• Diagnosis of twenty-six percent of liver cancer cases occurs following the cancer having metastasized to local lymph nodes or direct past the localized spot.
• Diagnosis of twenty-two percent of this disease cases occur subsequent to the cancer having shown metastasis (remote stage).
• Among twenty-two percent of liver cancer cases, the stage info was not known.

The equivalent 5-yr comparative survival rate for the disease on the basis of staging observed is:

• 

  3.4% – remote.

• Nineteen percent in case of localized.
• 6.6% in case of regionally located disease.
• 3.3% for non-staged disease.

Liver Cancer Prognosis & Mortality Rates

Since 1998 onwards till four years later, the avg. age of individuals dying from liver cancer has been observed to be seventy-one years old.

The % of liver cancer deaths as per age is:

The age-regulated liver cancer mortality rate was noted to be 4.7/100000 people from both genders annually. Such occurrences were on the basis of patients dying between 1998 till four years later in the U.S. Mortality rates in case of liver cancer as per ethnicity & gender are tabulated herewith.

Staging system is a standard approach that cancer-care teams deploy for summarizing info regarding how widespread the cancer is during diagnosis. Physicians deploy staging system for getting an idea regarding outlook of patients & determining apt therapy.

There are numerous staging systems in place for liver cancer & each doctor has his/her preference for using a particular staging system.

Liver Cancer Staging – TNM System

The TNM system is the main one deployed for describing liver cancer staging done on the basis of outcomes of the physical examination, imaging techniques (MRI, CAT scanning, and ultrasounds) among others.

The trio main segments of info are:

T depicts the centimetre measurement of sizes & numbers of primary tumors, & if cancer has managed to permeate organs close to the tumor.

N depicts how much the cancer has metastasized to regionally located lymph nodes.

M signifies if the cancer has spread to other regions of the body, the highly pervasive locations for metastasis in this disease is the bone, lung areas.

Numerals/lettering that is mentioned next to T, N, M offer further information regarding all such aspects:

• Nos. 0-4 suggest rising acuteness.
• Lettering X translates to ‘cannot-be-assessed’ since the data is unavailable.

T groupings

TX – assessment of primary tumor unattainable.

T0 – Absence of proof about primary tumor.

T1 – A solo tumor (irrespective of size) which has not shown growth inside the blood vessels

T2 – A solo tumor (irrespective of size) which has developed into blood vessels or multiple tumors where none are bigger than five centimetres or two inches athwart.

T3a – Several tumors among which one or more would be measuring over five centimetres or around two inches athwart.

T3b – A minimum of a single tumor which has developed inside a key branching of the big liver veins.

T4 – Tumor has spread inside an adjacent organ (apart from the gall bladder) or tumor growth inside the fine tissue sheath casing & encircling the liver.

N Groupings

NX – Assessing regionally located lymph nodes is not possible.

N0 – Cancer hasn’t metastasized to the close by lymph nodes.

N1 – Cancer metastasis to the local lymph nodes.

M Groupings

M0 – Cancer hasn’t metastasized to remote lymph nodes or organ types.

M1 – Cancer has metastasized to remote lymph nodes or organs.

Liver Cancer Staging Group

The T, N & M groups are then coalesced to present an overall stage.

Stage I: T1, N0, M0 –
Presence of one tumor (irrespective of size) which hasn’t spread within blood vessels. Cancerous presence hasn’t reached the close by lymph nodes or remote locations.

Stage II: T2, N0, M0 –
There’s a solo tumor (regardless of size) which has shown growth inside the blood vessels or presence of multiple tumors with each one measuring below five centimetres or two inches diameter-wise. Cancer hasn’t metastasized to close by lymph nodes or remote locations.

Stage IIIA: T3a, N0, M0 –
Existence of numerous tumors & a minimum of one measuring more than five centimetres athwart. Cancer hasn’t metastasized to close by lymph nodes or remote locations.

Stage IIIB: T3b, N0, M0 –
A minimum of one tumor growth has occurred inside a bough of the main liver blood vessels. Cancer hasn’t metastasized to close by lymph nodes or remote locations.

Stage IIIC: T4, N0, M0 –
Tumor growth inside a closely placed organ (excluding the gall bladder) or tumor growth has occurred inside the exterior casing of the liver. Cancer hasn’t metastasized to close by lymph nodes or remote locations.

Stage IVA: whichever T, N1, M0 –
Tumor presences in liver could be of whichever sizes or numbers & they might have permeated inside blood vessels or close by organs. The cancer has assaulted close by lymph nodes. Cancer hasn’t reached remote locations.

Stage IVB: whichever T, whichever N, M1 –
Cancer has reached other body areas. Tumor presences could be of whatever sizes or numbers & close by lymph nodes might or might not be affected.

Here are several liver cancer signs and symptoms that should be watched out for.

• Sharp-shooting spasm-like pains in the abdominal area close to the right-side of the ribcage.
• Feeling nauseous & puking because of bile-enzyme deficits necessary for digesting foods.
• Lost craving for food due to digestive process impacted.
• Swift reduction in weight as a result of lost hunger.
• Jaundice or yellowing of whites of the eyes, skin, clay-coloured stools.
• Inflated tummy alike an expectant mother – Ascites condition.
• Feeling frequently fatigued & muscular weakening.
• Frequently drowsy.
• Emotionally imbalanced such as being confused & restless.
• Infection-free & protracted fever.
• Urine colour might be of deeper tone as compared to normal.

Liver cancer is chiefly observed in the male gender and greater rates noticed among people in their forties. Cirrhosis of the liver (wherein scarring of usual tissue in the liver occurs due to inflammation as a result of incessant liver condition) is the key reason for this disease occurring. Liver cancer often develops among patients who suffer from hep B,C for protracted spans of time. Also abusing alcohol, chain smoking & regular steroid intake might be causal to liver cancer. Presence of arsenic in water could even be leading to liver cancer.

People need to understand that liver cancer signs and symptoms surface at a later staging that can be vastly perilous to the patient’s existence. Appropriate medicines & therapies help in controlling liver cancer mortalities. In case you are experiencing any of the just mentioned liver cancer signs and symptoms then promptly consulting your doctor is imperative.

Liver cancer types are segregated into trio groups, namely:

Localized resectable (several T1/T2, N0, M0 tumor types)
In case cancer is in a preliminary staging & the remnant liver is in good health, then surgical procedure – partial hepatectomy might help in curing the person. Regrettably, solely miniscule numbers of individuals having liver cancer would be part of this group. A crucial aspect which affects result is the tumor size & if it has developed in blood vessels. A large-sized tumor (over two inch athwart) or a tumor invading blood vessels has a greater likelihood of recurring in the liver or metastasizing to other areas post-surgery. The utility of the remnant of the organ & the individual’s overall health are also vital.

Scientific studies are presently probing if patients undergoing surgical procedure would be benefited when offered other therapies alongside surgical procedure. A trial found that chemo-embolization pre-surgery protracted life among several patient types post-surgery. In one trial those patient types offered interferon post-surgery had a greater likelihood of surviving twelve months post-surgery. Yet, there are several trials that disagree & further trials are necessary for uncovering the worth (in case any) for including other therapies to surgical procedure.

Localized unresectable (several T1-T4, N0, M0 tumor types)
These comprise of those tumor types which have not yet metastasized however are quite large-sized to be excised with safety. They include cancer which is present in particular regions which makes it trickier in removal, cancer forms with duo or more tumor types or cancer forms among patients having liver in poor condition. In such cases treatment by partial hepatectomy mostly isn’t an ideal choice and might rather require liver transplant in case doable. Liver transplant is a major surgery that involves removal & replacement of the organ with another healthy one by donors. Though it is a complicated procedure it has been helpful to several individuals and could treat cancer & any fundamental liver condition. The five-year survival rate in patient types that underwent liver transplantation for treating cancer in their livers is around sixty percent.

In case one is an inapt entrant for liver transplant then the physician might advice tumor ablation employing procedures. Some choices might comprise of embolization (alongside or not including chemotherapy or radiotherapy), targeted therapies using sorafenib, chemo (systemic/through hepatic artery infusion), &/or conformal radiotherapy.

Though it is quite improbable that therapy other than transplant would be cancer-curative, it could allay symptoms & lengthen life. However, such therapies are not identified to cure the disease; a scientific study is yet a favourable option.

Advanced (inclusive of every N1/M1 tumor types)
In this situation, the liver cancer has metastasized all through the organ or past the organ reaching the lymph nodes or some organ. Since such cancer types are common, they are not curable through surgical procedure.

In case the person’s liver functions satisfactorily – Child Pugh class A/B then targeted therapies with sorafenib might assist in controlling cancerous development for some period of time & might assist in prolonging existence.

Similar to localized resectable cancer, scientific studies on targeted therapy, novel strategies for chemo (novel medicines & regional chemo), novel types of radiotherapy (using radiosensitizer or target through antibodies) among other novel therapies (gene therapy, immunotherapies) might also be of assistance. Such scientific studies are additionally crucial for bringing about improvement in the prognosis of patient populaces in the near future.

Therapies like radiotherapy or chemo might be beneficial for allaying pains & other signs. Patients should preferably be discussing what symptoms they are experiencing with their cancer teams, so that their effective treatment could be carried out.

Recurring Liver Cancer Treatment
Cancer recurring or arising post-treatment could be at the analogous location or close to that location it originated or remote – metastasized to organ types like bones or lung. In such cases, therapy following preliminary treatment is based on several aspects like location of relapse, kind of preliminary therapy & extent to which the liver is functional. Those people having localized resectable condition which relapses in the analogous site might be offered additional surgery or local therapies such as embolizations or ablations. In case the cancer is extensive then targeted therapies using sorafenib or chemo might be the choices. Even such a patient could participate in on-going clinical trials apt for him/her. Therapy might even be given for allaying pains & other signs.

Particular heritable conditions additionally make one more inclined to developing liver cancer inclusive of tyrosinemia among infants, an atypical disorder that arises due to the body’s incapability of effectually breaking down tyrosine – an amino acid and uncured hemochromatosis – a disorder affecting adults that leads to the body absorbing and storing excessive amounts of iron. Chronic liver inflammation and wound are widespread to all such conditions.

Signs of Liver Cancer

• Liver cancer could be either primary or secondary also known as metastatic. Primary cancer originates in the liver and in its preliminary stages subsists solely inside the liver. Those having hepatitis B or C, viral infection affecting the liver or liver cirrhosis are more prone to developing primary liver cancer in comparison to other individuals. In the preliminary staging of liver cancer, the condition is asymptomatic. During advanced staging, the disease could lead to diminished appetite, reduction in weight, weariness and feeling weak.
• Secondary liver cancer is one that begins in another body organ like the colon, breasts, pancreas or stomach and then metastasizes to the liver. As secondary cancer affects no less than two organs, the treatment prospects are more restricted as compared to primary liver cancer. With the growth and spread of the cancer, pain could arise in the upper right part of the abdomen and could radiate into the back and the shoulder region.
• With advanced stages, liver failure signs start surfacing that involve abdominal swelling and feeling full or bloated and jaundice – a condition wherein there is yellowing of the skin and the white parts of the eyes and the urine turning dark in colour.

Diagnosis & Tests

For diagnosing liver cancer, the doctor would assess the patient’s medical history and conduct a meticulous physical exam after which some tests would be suggested. Those with heightened risk of getting liver cancer like those having chronic viral hepatitis or liver cirrhosis, the existing advice is to undergo an alpha-fetoprotein blood test and an ultrasound scan of the liver, at least on a yearly basis. Though not accurate, such tests raise the probability of liver cancer detection in preliminary stages.

• Particular kinds of blood analysis help to determine the level of the liver functioning.
• Chest and abdominal X-rays, angiogram or X-rays performed of the blood vessels, CAT scans, or X-rays developed by computers; and Magnetic resonance imaging (MRI) produced employing a magnetic field could be used during the diagnosis.
• In case there is doubt regarding the diagnosis, it could be corroborated by conducting a biopsy procedure. Tissues are taken from the liver via a needle or at the time of surgery and microscopically evaluated for detecting whether cancer cells are present. The doctor could additionally employ a tiny illuminated tube known as the laparoscope that is lighted on one tip for examining the liver. During this procedure a tiny incision is done on the abdominal region to facilitate the introduction of the laparoscope inside the patient’s body. During laparoscopy a tiny tissue sample is removed and sent for pathological examination to be evaluated microscopically for the presence of cancer. In case primary liver cancer has been diagnosed, further tests would be conducted for ascertaining whether the cancer cells have metastasized.

Staging

Below mentioned are the stages being used for adult primary liver cancer.

• Localized resectable
  Cancer is detected solely in one location in the liver and could be totally eradicated via surgery.
• Localized unresectable
  The cancer is present in just a single part of the liver, however could not be completely removed.
• Advanced Stage
  Cancer has metastasized to major areas of the liver or other body parts.
• Relapsed Stage
  Cancer has returned or recurred following treatment affecting the liver or another section of the body.

Liver Cancer Treatment

• Surgery
  Surgery is the prevalent line of treatment for liver cancer.
• Radiation Therapy
  Radiation therapy employs X-rays or other kinds of high-power beams for obliterating cancer cells and shrivelling the tumors. The radiation rays emanate from a machine that is placed outside the body also called as external radiation therapy. Radiation could be employed by itself or alongside surgery and chemotherapy.
• Chemotherapy
  During chemotherapy, drugs are used for killing the cancerous cells. Chemotherapy done for liver cancer is generally administered to the body by introducing a needle inside the vein or the artery. This form of chemotherapy is known as systemic treatment as the drugs makes an entry inside the bloodstream, travelling throughout the body and could annihilate cancerous cells spread beyond the liver. In another form of chemotherapy known as regional chemotherapy, a small-sized pump filled with the cancer-combatant drugs are placed inside the body. The pump slowly releases the drug direct inside the blood vessels known as arteries that then reach the tumor.